[NBY] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[NBY] NovaBay Pharmaceuticals, Inc.
Announcement Date
09-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 56.42%
YoY- 69.67%
Quarter Report
NBY's Result
NBY's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 2,400 2,631 3,727 3,255 4,610 3,124 3,643 -24.30%
PBT -1,585 -3,090 -4,108 -1,757 -2,036 -1,739 -8,206 -66.61%
Tax 0 124 302 -51 -256 5 -3,488 -
NP -1,585 -3,214 -4,108 -1,757 -4,032 -1,739 -8,206 -66.61%
Tax Rate - - - - - - - -
Total Cost 3,985 5,845 7,835 5,012 8,642 4,863 11,849 -51.67%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -66.04 -122.16 -110.22 -53.98 -87.46 -55.67 -225.25 -55.90%
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -1.37 -4.92 -46.53 -13.11 -40.92 -23.13 -151.72 -95.67%
EPS Diluted -1.37 -4.92 -46.53 -13.11 -40.92 -23.13 -151.72 -95.67%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.